TRANSCAN-3 JTC 2024 “Combination therapies against cancer: new opportunities for translational research”
Canadian Institutes of Health Research (CIHR)
The main purpose of this call will be design of patient preclinical models for combination therapies. Translational research using tumour samples collected from retrospective and/or prospective cohorts of patients.
The maximum amount per grant is $450,000.00 for up to three years for Canadian research teams.
Anticipated Notice of Decision: May 2025
Funding Start Date: September 2025
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Pre-Application | 24-Jun-2024 4:30 pm CST | 05-Jul-2024 12:00 pm CST |
Application (Upon Invitation Only) | 19-Nov-2024 4:30 pm CST | 29-Nov-2024 12:00 pm CST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.